Specific batches of 60 drugs have failed quality tests in sample-based screening of Central Drugs Standard Control Organization (CDSCO)
Some of the most common pills like Combiflam and D-Cold consumed in India has been recently decalared as sub-standard by Indian drug regulator, CDSCO.
Specific batches of 60 drugs have failed quality tests in sample-based screening of Central Drugs Standard Control Organization (CDSCO).
Both the batches of Combiflam and D-Cold tablets failed the test because of "disintegration" issues. Reason of failure for Cetrizine was "related substances". Ofloxacine and ciprofloxacine failed "assay" which is a quantitative tests for ingredients. A gentamicine injection failed the test for "particulate matter". Pantoprazo failed the test for "dissolution".
The 60 drugs which have found their way into the 'substandard' list are as below:
“We plan to introduce 25 new t...
“We leverage India as a market...
"We need policies for building...
Ensure access to pumps and CGM
ICMR & IISc to create gold sta
Alkem Labs, Stempeutics get DC
Merck opens R&D Excellence Centre i
Oncology, digital health startups t
C-CAMP, USAID launch respiratory su
Can mRNA technology prove to be beneficial for the Indian biopharma sector?
Ashirwad Bungalow, First floor, 36/A/2, S.No. 270, Pallod Farms, Near Bank of Baroda, Baner Road, Pune, Maharashtra, India 411045 Mob : +91-9579069369 Email : communications@mmactiv.com
© 2022 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer
Web Interface Conceived and Powered By : SCI Knowledge Interlinks